[
  {
    "name": "Standard Protocol (Depression)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 120.0,
    "frequency_hz_init": 10.0,
    "pulses_per_train": 40,
    "train_count": 75,
    "inter_train_interval_s": 26.0,
    "target_region": "LDLPFC",
    "description": "Standard 10 Hz rTMS protocol for depression; FDA approved 2008",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  },

  {
    "name": "Dash Protocol (Depression)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 120.0,
    "frequency_hz_init": 10.0,
    "pulses_per_train": 40,
    "train_count": 75,
    "inter_train_interval_s": 11.0,
    "target_region": "LDLPFC",
    "description": "Dash 10 Hz rTMS protocol for depression; FDA cleared 2016",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  },

  {
    "name": "iTBS Protocol (Depression)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 120.0,
    "frequency_hz_init": 50.0,
    "pulses_per_train": 30,
    "train_count": 20,
    "inter_train_interval_s": 8.0,
    "target_region": "LDLPFC",
    "description": "Intermittent theta-burst stimulation (iTBS) protocol for depression; FDA approved 2018",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic Burst",
    "burst_pulses_count_init": 3,
    "inter_pulse_interval_ms_init": 20.0
  },

  {
    "name": "Adolescent Depression (Brainsway)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 120.0,
    "frequency_hz_init": 10.0,
    "pulses_per_train": 40,
    "train_count": 75,
    "inter_train_interval_s": 11.0,
    "target_region": "LDLPFC",
    "description": "10 Hz rTMS Brainsway protocol for adolescent depression; FDA clearance 2024",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  },

  {
    "name": "Adolescent Depression iTBS (Brainsway)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 120.0,
    "frequency_hz_init": 50.0,
    "pulses_per_train": 30,
    "train_count": 20,
    "inter_train_interval_s": 8.0,
    "target_region": "LDLPFC",
    "description": "iTBS Brainsway protocol for adolescent depression; FDA clearance 2024",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 3,
    "inter_pulse_interval_ms_init": 20.0
  },

  {
    "name": "Low-Frequency 1 Hz Right DLPFC (Depression)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 120.0,
    "frequency_hz_init": 1.0,
    "pulses_per_train": 600,
    "train_count": 2,
    "inter_train_interval_s": 30.0,
    "target_region": "RDLPFC",
    "description": "1 Hz low-frequency rTMS protocol for depression",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  },

  {
    "name": "Bilateral Sequential Right 1 Hz (Depression)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 120.0,
    "frequency_hz_init": 1.0,
    "pulses_per_train": 900,
    "train_count": 1,
    "inter_train_interval_s": 0.1,
    "target_region": "RDLPFC",
    "description": "Right-sided 1 Hz part of bilateral sequential rTMS protocol for depression",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  },

  {
    "name": "Bilateral Sequential Left 10 Hz (Depression)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 120.0,
    "frequency_hz_init": 10.0,
    "pulses_per_train": 40,
    "train_count": 75,
    "inter_train_interval_s": 11.0,
    "target_region": "LDLPFC",
    "description": "Left-sided 10 Hz part of bilateral sequential rTMS protocol for depression",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  },

  {
    "name": "OCD Deep TMS 20 Hz (Brainsway)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 100.0,
    "frequency_hz_init": 20.0,
    "pulses_per_train": 40,
    "train_count": 50,
    "inter_train_interval_s": 20.0,
    "target_region": "ACC-mPFC",
    "description": "Deep TMS with H7 coil over ACC-mPFC for OCD; Brainsway protocol, FDA approved 2018",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  },

  {
    "name": "OCD DMPFC 20 Hz (MagVenture)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 100.0,
    "frequency_hz_init": 20.0,
    "pulses_per_train": 40,
    "train_count": 50,
    "inter_train_interval_s": 20.0,
    "target_region": "DMPFC",
    "description": "20 Hz rTMS over DMPFC for OCD using Double-cone / cool D-B80 coil; MagVenture protocol, FDA 2020",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  },

  {
    "name": "Smoking Craving 10 Hz (Brainsway)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 120.0,
    "frequency_hz_init": 10.0,
    "pulses_per_train": 30,
    "train_count": 60,
    "inter_train_interval_s": 15.0,
    "target_region": "PFC-Insula",
    "description": "10 Hz rTMS over prefrontal cortex and insula for smoking craving; Brainsway protocol, FDA clearance 2021",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  },

  {
    "name": "Craving 15 Hz LDLPFC (MagVenture)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 100.0,
    "frequency_hz_init": 15.0,
    "pulses_per_train": 60,
    "train_count": 40,
    "inter_train_interval_s": 15.0,
    "target_region": "LDLPFC",
    "description": "15 Hz rTMS over LDLPFC for substance-use craving; MagVenture protocol, CE approval",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  },

  {
    "name": "Comorbid Anxiety Neurostar 20 Hz (FDA 2022)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 120.0,
    "frequency_hz_init": 20.0,
    "pulses_per_train": 40,
    "train_count": 55,
    "inter_train_interval_s": 20.0,
    "target_region": "LDLPFC",
    "description": "20 Hz Neurostar protocol for anxiety symptoms comorbid with depression; FDA clearance 2022",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  },

  {
    "name": "Comorbid Anxiety Brainsway 10 Hz (FDA 2022)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 120.0,
    "frequency_hz_init": 10.0,
    "pulses_per_train": 40,
    "train_count": 75,
    "inter_train_interval_s": 11.0,
    "target_region": "LDLPFC",
    "description": "10 Hz Brainsway protocol for anxiety symptoms comorbid with depression; FDA clearance 2022",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  },

  {
    "name": "Comorbid Anxiety Bilateral Right 1 Hz (MagVenture)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 110.0,
    "frequency_hz_init": 1.0,
    "pulses_per_train": 900,
    "train_count": 1,
    "inter_train_interval_s": 0.0,
    "target_region": "RDLPFC",
    "description": "Right 1 Hz part of bilateral MagVenture protocol for anxiety comorbid with depression; CE approval",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  },

  {
    "name": "Comorbid Anxiety Bilateral Left 10 Hz (MagVenture)",
    "subject_mt_percent_init": 0.0,
    "intensity_percent_of_mt_init": 110.0,
    "frequency_hz_init": 10.0,
    "pulses_per_train": 50,
    "train_count": 30,
    "inter_train_interval_s": 25.0,
    "target_region": "LDLPFC",
    "description": "Left 10 Hz part of bilateral MagVenture protocol for anxiety comorbid with depression; CE approval",
    "ramp_fraction": 1.0,
    "ramp_steps": 1,
    "waveform": "Biphasic",
    "burst_pulses_count_init": 1,
    "inter_pulse_interval_ms_init": 10.0
  }
]
